Affymax Sued Over $500M Stock Drop Linked To Recall
An Affymax Inc. shareholder hit the biopharmaceutical company and its partner Takeda Pharmaceutical Co. Ltd. with a putative class action Wednesday in California federal court, saying their failure to disclose that...To view the full article, register now.
Already a subscriber? Click here to view full article